An example of the use of DMSO as a drug carrier in the Alzheimer’s disease (AD) field is the work on selective inhibitors of Glycogen Synthase Kinase-3 β (GSK-3β) in vivo and in vivo[7]–[10]. This evidence concerns the gene GSK3B and Alzheimer disease.